CN1058631C - Psoriasis capsule - Google Patents
Psoriasis capsule Download PDFInfo
- Publication number
- CN1058631C CN1058631C CN98100151A CN98100151A CN1058631C CN 1058631 C CN1058631 C CN 1058631C CN 98100151 A CN98100151 A CN 98100151A CN 98100151 A CN98100151 A CN 98100151A CN 1058631 C CN1058631 C CN 1058631C
- Authority
- CN
- China
- Prior art keywords
- radix
- percentage
- fructus
- weight
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a psoriasis capsule which is prepared from four kinds of medicinal prescriptions. All the prescriptions has the weight percentage that the first prescription has 1 to 5 of bezoar, 5 to 20 of pearl, 6 to 30 of root-bark of ditlany, 10 to 30 of campsis grandiflora, 6 to 20 of leitai rattan, 9 to 20 of sophora flower; the second prescription has 10 to 20 of snow lotuse, 10 to 20 of pearl, 10 to 20 of plaster stone, 8 to 18 of black-tail snake, 5 to 15 of fructus aurantii, 5 to 15 of dahurian angelica and 5 to 15 of great burdock achene; the third prescription has 8 to 20 of crude dragon bone, 7 to 20 of oyster, 10 to 30 of cassia tora, 8 to 20 of natural indigo, 8 to 20 of selfheal spike, 5 to 20 of green tangerine peel, 5 to 15 of fructus aurantii, 10 to 30 of kakuda figwort root, 3 to 15 of stemona root, 8 to 20 of pearl and 1 to 5 of cornua rhinoceri pallidumthread; the third prescription has 3 to 13 of rehmannia root, 2 to 5 of liquorice, 5 to 15 of astragalus root, 4 to 8 of angelica, 0.5 to 3 of frankincense, 0.5 to 2 of myrrh, 0.5 to 1.5 of hemlock parsley, 1 to 4 of tortoise plastron, 1 to 3 of donkey-hide gelatin, 1.5 to 5 of fructus aurantii, 1 to 3 of shuangpige, 0.5 to 3 of pinellia tuber, 0.5 to 1.5 of platycodon root, 0.5 to 2.5 of bupleurum root, 3 to 9 of keel, 2 to 6 of oyster, 1 to 5 of medicated leaven, 1 to 3 of Chicken's Gizzard-membrane, 0.5 to 1.5 of gardenia, 2 to 8 of american ginseng and 1 to 3 of caterpillar fungus. The present invention has the advantages of high cure rate, no easy recurrence, etc.
Description
The present invention relates to the psoriatic psoriasis capsule of a kind of treatment, belong to the dermopathic Chinese medicinal capsule of treatment.
Psoriasis is a kind of common dermatosis with chronic, easy recurrence of characteristic skin lesion, and at present, of a great variety for the Therapeutic Method of this disease, it is low that many Therapeutic Method all have cure rate, easily deficiency such as recurrence.Delivered Gu Chuan, the river show employing bitter guarantor of leakage material and polyvalent unsaturated fatty acid according to seven kinds of dermatosis magazines of Japanese 90-95 and treated psoriatic six pieces of reports, its cure rate is zero.Reports such as Germany Hermeickvon and the RPmwK0TH of Russia have only been reported effective percentage and have been respectively 98% and 95%.Domestic report is with traditional Chinese medical herbal treatment curative effect the best, and cure rate is at 20-67%, and is only applicable to homeliness type.The method that adopts Chinese and western medicine to combine does not in addition have breakthrough curative effect yet.The Chinese medicine of employing photochemical therapy is arranged at present, optical photon therapy, blood magnetotherapy, autohemotherapy, catgut embedding therapy, dialysis therapy etc. again.Wherein photochemical therapy, blood magnetotherapy curative effect the best, but there is unsurmountable shortcoming, selection, irradiation time as its wavelength of photochemical therapy are subjected to all multifactor influences as season, sex, age, position, the colour of skin, nutrition, situation, endocrine factors, disease situation, dosage is difficult for grasping, and improper use causes adverse consequences on the contrary.Buy expensive blood magnetizing machine but the blood magnetotherapy is essential, medical expense costliness, and patient Duo Yin blood vessel is in bad order, factor such as be in a bed economic state, the course of treatment that often can not finish defined.
The objective of the invention is to overcome many deficiencies of above-mentioned prior art and a kind of cure rate height is provided, short treating period, four kinds of capsules are taken continuously, and toxic and side effects is light, economical and practical psoriasis capsule.
The object of the present invention is achieved like this: it is made of four kinds of prescriptions, and prescription 1 is made up of six kinds of Chinese medicines, and each component and percentage by weight thereof are Calculus Bovis 1-5, Margarita 5-20, Cortex Dictamni 6-30, Flos Campsis 10-30, thunder platform rattan 6-20, Flos Sophorae 9-20.Prescription 2 is made of eight kinds of Chinese medicines, and each component and percentage by weight thereof are Herba Saussureae Involueratae 10-20, Margarita 10-20, Gypsum Fibrosum 10-20, Zaocys 8-18, Fructus Aurantii 5-15, Indigo Naturalis 5-15, Radix Angelicae Dahuricae 5-15, Fructus Arctii 5-15.Prescription 3 is made of 11 kinds of Chinese medicines, and each component and percentage by weight thereof are Os Draconis 8-20, Concha Ostreae 7-20, Concha Haliotidis 10-30, Indigo Naturalis 5-15, Spica Prunellae 8-20, Pericarpium Citri Reticulatae Viride 5-20, Fructus Aurantii 5-15, Radix Scrophulariae 10-30, Radix Stemonae 3-15, Margarita 8-20, Radix Rumicis silk 1-5.Prescription 4 is made of 22 kinds of Chinese medicines, and each component and percentage by weight thereof are Radix Rehmanniae 3-13, Radix Glycyrrhizae 2-5, Hemerocallis citrina Baroni 5-15, Radix Angelicae Sinensis 4-8, Olibanum 0.5-3, Myrrha 0.5-2, Rhizoma Chuanxiong 0.5-1.5, Carapax et Plastrum Testudinis 1-4, Colla Corii Asini 1-3, Fructus Aurantii 1.5-5, Cortex Mori 1-3, Rhizoma Pinelliae 0.5-3, Radix Platycodonis 0.5-1.5, Radix Bupleuri 0.5-2.5, Os Draconis 3-9, Concha Ostreae 2-6, Massa Medicata Fermentata 1-5, Fructus Hordei Germinatus 5-15, Endothelium Corneum Gigeriae Galli 1-3, Fructus Gardeniae 0.5-1.5, Radix Panacis Quinquefolii 2-8, Cordyceps 1-3.Purpose of the present invention can also realize by following technical measures: the component and the percentage by weight thereof of prescription 1 can be Calculus Boviss 3.6, Margarita 18.2, Cortex Dictamni 16.3, Flos Campsis 27.3, Radix Tripterygii Wilfordii 16.4, Flos Sophorae 18.2.The component of described prescription 2 and percentage by weight can be Herba Saussureae Involueratae 15, Margarita 15, Gypsum Fibrosum 15, Zaocys 15, Fructus Aurantii 10, Indigo Naturalis 10, the Radix Angelicae Dahuricae 10, Fructus Arctii 10.The component and the percentage by weight of prescription 3 can be Os Draconis 9.3, Concha Ostreae 9.3, Concha Haliotidis 15.4, Indigo Naturalis 9.3, Spica Prunellae 12.3, Pericarpium Citri Reticulatae Viride 9.3, Fructus Aurantii 6.2, Radix Scrophulariae 12.2, the Radix Stemonae 6.2, Margarita 9.3, Radix Rumicis silk 1.2.The component of described prescription 4 and percentage by weight can be the Radix Rehmanniae 10.3, Radix Glycyrrhizae 3.2, the Radix Astragali 13.9, Radix Angelicae Sinensis 7.7, Olibanum 1.9, Myrrha 1.9, Rhizoma Chuanxiong 1.3, Carapax et Plastrum Testudinis 3.9, Colla Corii Asini 2.6, Fructus Aurantii 3.2, Cortex Mori 1.9, the Rhizoma Pinelliae 1.9, Radix Platycodonis 1.3, Radix Bupleuri 1.9, Os Draconis 7.7, Concha Ostreae 5.2, Massa Medicata Fermentata 3.2, Fructus Hordei Germinatus 13.9, Endothelium Corneum Gigeriae Galli 2.7, Fructus Gardeniae 1.3, Radix Panacis Quinquefolii 6.5, Cordyceps 2.6.Above-mentioned prescription is ground into respectively do not make capsule, the heavy 0.6g of every ball.
Compared to existing technology, the present invention has the following advantages:
1, cure rate height reaches 97%, adds basic healing, and cure rate can reach 100%.
2, short treating period is generally healing in 15-30 days.
3, toxic and side effects is slight, and hepatic and renal function is not had influence.
4, be applicable to all kinds, the psoriasis of each phase.
5, treatment back skin recovers normal fully.
6, pharmaceutical methods, instructions of taking is simple, is applicable to hospitals at different levels, and clinic uses.
7, price is cheap, and the medicine source is extensive, is easy to processing.
8, relapse rate is low, and medicine is reusable, and recurrence treatment again has identical curative effect.
Pharmacological action of the present invention.
The effect of the pharmacology of No. 1 medicine (prescription 1): have clearing away heat,cooling blood and removing toxin, activating blood circulation to dissipate blood stasis, blood enriching and dryness moistening, the effect of dispelling wind for relieving itching.
No. 2 medicines (prescription 2) compensate qi and blood, expelling wind and removing dampness, promoting blood circulation to remove obstruction in the collateral, removing scurf and relieving itching.
No. 3 medicines (prescription 3): clearing away heat-fire, detoxicatied spot-removing, parasite killing granulation promoting, the soft kidney of cloudy now YANG hyperactivity suppressing.
No. 4 medicines (prescription 4) wind-damp dispelling, strong muscle is mended bone water, QI invigorating YANG invigorating, eliminating stagnation.
The biological alkali and the terpenoid of 1-4 medicine have following pharmacological action:
1, can suppress antibody forms.Modern study confirms that IgA and IgE raise in psoriatic's serum, also have anti-IgG antibody simultaneously, and anti-cutin autoantibody is arranged in horny layer, so the 1-4 series Chinese medicine tissue injury that can suppress immunoreation and be caused.
2, patient CAnP/CGMP ratio is starkly lower than the normal person before the treatment, and CAMP descends, and can cause that epidermis cell has floating division growth too fast, thereby row causes that keratinization of epidermis is incomplete, treats the latter two ratios and recovers normal.
3, can suppress basal cell, thus the too fast Parakeratotic pathological process of horny layer that changed of prickle cell layer division growth.
4, microcirculation improvement, reduce blood viscosity and improve blood platelet disorders gathering and adhesion, evidence diseased region microcirculation changes and will disappear several months even 1 year ability recovery normally at skin lesion, the performance of aberrant angiogenesis bending is also arranged at skin lesions circumferece normal appearance skin, this illustrates that psoriatic generation development may be to occur corium blood capillary ANOMALOUS VARIATIONS earlier, the clinical skin lesion that can see then could occur, this just provides strong theoretical foundation for the activating blood circulation to dissipate blood stasis treatment psoriasis of Chinese medicine.
5, the 1-4 medical instrument has the antiinflammatory sterilization, and effects such as antiallergic are also played good effect undoubtedly to psoriasis.
Below in conjunction with embodiment in detail the present invention is described in detail.
The present invention is by the 1-4 medicine, and the 1-4 that both filled a prescription forms, and wherein No. 1 medicine is made up of Calculus Bovis, Margarita, Cortex Dictamni, Flos Campsis, Radix Tripterygii Wilfordii, six kinds of Chinese medicines of Flos Sophorae, and its formulation Example is represented with following table 1:
Table 1
| The medicine name | Weight percent content | |||||||
| Calculus Bovis | 3.6 | 1 | 2 | 5 | 4 | 4 | 3 | 5 |
| Margarita | 18.2 | 19 | 5 | 20 | 20 | 18 | 20 | 10 |
| Cortex Dictamni | 16.3 | 28 | 30 | 26 | 6 | 30 | 24 | 19 |
| Flos Campsis | 27.3 | 15 | 30 | 25 | 30 | 10 | 29 | 26 |
| Radix Tripterygii Wilfordii | 16.4 | 17 | 20 | 6 | 20 | 19 | 15 | 20 |
| Flos Sophorae | 18.2 | 20 | 13 | 18 | 20 | 19 | 9 | 20 |
No. 2 medicine is made up of Herba Saussureae Involueratae, Margarita, Gypsum Fibrosum, Zaocys, Fructus Aurantii, Indigo Naturalis, the Radix Angelicae Dahuricae, eight kinds of Chinese medicines of Fructus Arctii, and its formulation Example is represented with following table 2:
Table 2
| The medicine name | Weight percent content (%) | ||||
| Herba Saussureae Involueratae | 15 | 10 | 14 | 20 | 18 |
| Margarita | 15 | 20 | 18 | 10 | 14 |
| Gypsum Fibrosum | 15 | 10 | 20 | 18 | 17 |
| Zaocys | 15 | 8 | 18 | 10 | 9 |
| Fructus Aurantii | 10 | 15 | 5 | 8 | 11 |
| Indigo Naturalis | 10 | 8 | 15 | 5 | 13 |
| The Radix Angelicae Dahuricae | 10 | 15 | 5 | 14 | 9 |
| Fructus Arctii | 10 | 14 | 5 | 15 | 9 |
No. 3 medicine is made up of Os Draconis, domestic animal oyster, Concha Haliotidis, Indigo Naturalis Spica Prunellae, Pericarpium Citri Reticulatae Viride, Fructus Aurantii, Radix Scrophulariae, the Radix Stemonae, Margarita, 11 kinds of Chinese medicines of Radix Rumicis silk, and its formulation Example is represented with following table 3:
Table 3
No. 4 medicine Radix Rehmanniae, Radix Glycyrrhizae, the Radix Astragali, Radix Angelicae Sinensis, Olibanum, Myrrha, Rhizoma Chuanxiong, Carapax et Plastrum Testudinis, Colla Corii Asini, Fructus Aurantii, Cortex Mori each, the Rhizoma Pinelliae, Radix Platycodonis, Radix Bupleuri, Os Draconis, Concha Ostreae, Massa Medicata Fermentata, Fructus Hordei Germinatus, Endothelium Corneum Gigeriae Galli, Fructus Gardeniae, Radix Panacis Quinquefolii, 22 kinds of Chinese medicines of Cordyceps form.Its formulation Example is represented with following table 4:
| The medicine name | Weight percent content (%) | ||||||||
| Os Draconis | 9.3 | 20 | 10 | 12 | 8 | 9 | 8 | 8 | 9 |
| Concha Ostreae | 9.3 | 7 | 10 | 20 | 7 | 8 | 7 | 9 | 7 |
| Concha Haliotidis | 15.4 | 10 | 30 | 10 | 13 | 10 | 10 | 10 | 10 |
| Indigo Naturalis | 9.3 | 15 | 8 | 10 | 8 | 8 | 9 | 8 | 20 |
| Spica Prunellae | 12.3 | 8 | 8 | 8 | 10 | 8 | 10 | 8 | 20 |
| Pericarpium Citri Reticulatae Viride | 9.3 | 5 | 5 | 5 | 7 | 5 | 6 | 20 | 5 |
| Fructus Aurantii | 6.2 | 5 | 5 | 5 | 8 | 5 | 6 | 15 | 5 |
| Radix Scrophulariae | 12.2 | 10 | 11 | 10 | 15 | 20 | 30 | 10 | 10 |
| The Radix Stemonae | 6.2 | 3 | 4 | 5 | 3 | 15 | 3 | 3 | 4 |
| Margarita | 9.3 | 16 | 8 | 10 | 20 | 11 | 8 | 8 | 8 |
| The Radix Rumicis silk | 1.2 | 1 | 1 | 5 | 1 | 1 | 3 | 1 | 2 |
Table 4
| The medicine name | Weight percent content (%) | |||||||
| The Radix Rehmanniae | 10.3 | 5 | 9 | 3 | 13 | 13 | 13 | 12 |
| Radix Glycyrrhizae | 3.2 | 5 | 4 | 2 | 5 | 5 | 5 | 4 |
| The Radix Astragali | 13.9 | 15 | 13 | 15 | 5 | 15 | 15 | 14 |
| Radix Angelicae Sinensis | 7.7 | 8 | 5 | 8 | 8 | 4 | 8 | 8 |
| Olibanum | 1.9 | 0.5 | 3 | 2 | 3 | 3 | 3 | 3 |
| Myrrha | 1.9 | 2 | 0.5 | 2 | 1 | 2 | 2 | 2 |
| Rhizoma Chuanxiong | 1.3 | 0.5 | 1.5 | 1 | 1.5 | 1.5 | 1 | 1.5 |
| Carapax et Plastrum Testudinis | 3.9 | 3 | 4 | 4 | 3 | 1 | 4 | 4 |
| Colla Corii Asini | 2.6 | 2 | 3 | 1 | 3 | 3 | 3 | 3 |
| Fructus Aurantii | 3.2 | 5 | 1.5 | 5 | 4 | 5 | 5 | 5 |
| Cortex Mori | 1.9 | 1 | 3 | 3 | 2.5 | 3 | 3 | 3 |
| The Rhizoma Pinelliae | 1.9 | 0.5 | 3 | 3 | 2.5 | 3 | 3 | 3 |
| Radix Platycodonis | 1.3 | 0.5 | 1.5 | 1.5 | 1 | 1.5 | 1.5 | 1.5 |
| Radix Bupleuri | 1.9 | 2.5 | 2 | 2.5 | 0.5 | 2.5 | 2 | 2.5 |
| Os Draconis | 7.7 | 9 | 8 | 9 | 8 | 7 | 5 | 3 |
| Concha Ostreae | 5.2 | 6 | 6 | 6 | 5 | 6 | 3 | 2 |
| Massa Medicata Fermentata | 3.2 | 5 | 5 | 4 | 5 | 5 | 1 | 5 |
| Fructus Hordei Germinatus | 13.9 | 15 | 14 | 15 | 15 | 5 | 15 | 9 |
| Endothelium Corneum Gigeriae Galli | 2.7 | 3 | 2 | 3 | 2.5 | 3 | 1 | 3 |
| Fructus Gardeniae | 1.3 | 0.5 | 1.5 | 1 | 1.5 | 1.5 | 1.5 | 1.5 |
| Radix Panacis Quinquefolii | 6.5 | 8 | 7.5 | 8 | 7 | 7 | 2 | 6 |
| Cordyceps | 2.6 | 3 | 2 | 1 | 3 | 3 | 3 | 2 |
Method for production of the present invention: above-mentioned 1-4 medicine screened respectively remove impurity, oven dry is ground into fine powder, crosses sieve No. 5, by the formulation weight mixing, packs in " 0 " number capsule, is finished product, every heavy 0.6g.
Capsular quality standard:
Moisture content: 90% ± 10%
Disintegration: 12 minutes standards: 30 minutes
Assorted bacterium: 198/g standard: 30-300/g
Escherichia coli: no standard: do not have individual/g
Acarid bacterium: no standard: do not have individual/g
Above-mentioned standard meets " one one of 95 years version of Chinese pharmacopoeia fully.
Instructions of taking of the present invention:
1-4 medicine of the present invention and Western medicine are used, and method is:
1, transfusion earlier defeated vitamin C 3-10 days, stops taking the present invention behind the liquid.
2, first No. 1 medicine of clothes, every day twice, each 2, take 5 days after, obey medicine 5-8 grain No. 2, take and take No. 1 medicine after 5 days again every day three times, every day twice, each 2, took 5 days, 15 days is a course of treatment altogether, takes No. 4 medicine every days 3 times then, each 2.Consolidate a course of treatment (7 days), the recidivist takes medicine 5-8 grain No. 3, and every day 3 times, each 2,7 days is a course of treatment.
Three groups of therapeutic effect statistical tables
| Grouping | Total routine number | Cure | The basic healing | Produce effects | Take a turn for the better | Sum | |||||
| The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | ||
| The treatment group | 30 | 29 | 97 | 1 | 3 | ||||||
| Matched group | 30 | 15 | 50 | 9 | 30 | 4 | 13.3 | 1 | 3.3 | ||
| Matched group | 30 | 30 | 100 | ||||||||
Claims (8)
1, a kind of psoriasis capsule is characterized in that: each component and percentage by weight are Calculus Bovis 1-5, Margarita 5-20, Cortex Dictamni 6-30, Flos Campsis 10-30, Radix Tripterygii Wilfordii 6-20, Flos Sophorae 9-20;
2, a kind of psoriasis capsule is characterized in that: each component and percentage by weight are Herba Saussureae Involueratae 10-20, Margarita 10-20, Gypsum Fibrosum 10-20, Zaocys 8-18, Fructus Aurantii 5-15, Indigo Naturalis 5-15, Radix Angelicae Dahuricae 5-15, Fructus Arctii 5-15.
3, a kind of psoriasis capsule is characterized in that: each component and percentage by weight are Os Draconis 8-20, Concha Ostreae 7-20, Concha Haliotidis 10-30, Indigo Naturalis 5-15, Spica Prunellae 8-20, Pericarpium Citri Reticulatae Viride 5-20, Fructus Aurantii 5-15, Radix Scrophulariae 10-30, Radix Stemonae 3-15, Margarita 8-20, Radix Rumicis silk 1-5;
4, a kind of psoriasis capsule is characterized in that: each component and percentage by weight are Radix Rehmanniae 3-13, Radix Glycyrrhizae 2-5, Hemerocallis citrina Baroni 5-15, Radix Angelicae Sinensis 4-8, Olibanum 0.5-3, Myrrha 0.5-2, Rhizoma Chuanxiong 0.5-1.5, Carapax et Plastrum Testudinis 1-4, Colla Corii Asini 1-3, Fructus Aurantii 1.5-5, Cortex Mori 1-3, Rhizoma Pinelliae 0.5-3, Radix Platycodonis 0.5-1.5, Radix Bupleuri 0.5-2.5, Os Draconis 3-9, Concha Ostreae 2-6, Massa Medicata Fermentata 1-5, Fructus Hordei Germinatus 5-15, Endothelium Corneum Gigeriae Galli 1-3, Fructus Gardeniae 0.5-1.5, Radix Panacis Quinquefolii 2-8, Cordyceps 1-3.
5, psoriasis capsule according to claim 1 is characterized in that each component and percentage by weight thereof are Calculus Bovis 3.6, Margarita 18.2, Cortex Dictamni 16.3, Flos Campsis 27.3, Radix Tripterygii Wilfordii 16.4, Flos Sophorae 18.2.
6, psoriasis capsule according to claim 2 is characterized in that each component and percentage by weight thereof are Herba Saussureae Involueratae 15, Margarita 15, Gypsum Fibrosum 15, Zaocys 15, Fructus Aurantii 10, Indigo Naturalis 10, the Radix Angelicae Dahuricae 10, Fructus Arctii 10.
7, psoriasis capsule according to claim 3 is characterized in that each component and percentage by weight thereof are Os Draconis 9.3, Concha Ostreae 9.3, Concha Haliotidis 15.4, Indigo Naturalis 9.3, Spica Prunellae 12.3, Pericarpium Citri Reticulatae Viride 9.3, Fructus Aurantii 6.2, Radix Scrophulariae 12.2, the Radix Stemonae 6.2, Margarita 9.3, Radix Rumicis silk 1.2.
8, psoriasis capsule according to claim 4 is characterized in that each component and percentage by weight thereof are the Radix Rehmanniae 10.3, Radix Glycyrrhizae 3.2, the Radix Astragali 13.9, Radix Angelicae Sinensis 7.7, Olibanum 1.9, Myrrha 1.9, Rhizoma Chuanxiong 1.3, Carapax et Plastrum Testudinis 3.9, Colla Corii Asini 2.6, Fructus Aurantii 3.2, Cortex Mori 1.9, the Rhizoma Pinelliae 1.9, Radix Platycodonis 1.3, Radix Bupleuri 1.9, Os Draconis 7.7, Concha Ostreae 5.2, Massa Medicata Fermentata 3.2, Fructus Hordei Germinatus 13.9, Endothelium Corneum Gigeriae Galli 2.7, Fructus Gardeniae 1.3, Radix Panacis Quinquefolii 6.5, Cordyceps 2.6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98100151A CN1058631C (en) | 1998-01-22 | 1998-01-22 | Psoriasis capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98100151A CN1058631C (en) | 1998-01-22 | 1998-01-22 | Psoriasis capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1223870A CN1223870A (en) | 1999-07-28 |
| CN1058631C true CN1058631C (en) | 2000-11-22 |
Family
ID=5215838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98100151A Expired - Fee Related CN1058631C (en) | 1998-01-22 | 1998-01-22 | Psoriasis capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1058631C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784296B (en) * | 2012-08-19 | 2013-12-18 | 徐海波 | Fructus trichosanthis oral liquid |
| CN102805835A (en) * | 2012-09-06 | 2012-12-05 | 韩秀芳 | Method for treating psoriasis by traditional Chinese medicine |
| CN103893632B (en) * | 2014-04-16 | 2016-04-13 | 武海明 | One treats psoriasic Chinese medicine composition |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080865A (en) * | 1993-01-05 | 1994-01-19 | 梁建奇 | Dermopathic Chinese medicine of a kind of treatment and preparation method |
| CN1128668A (en) * | 1995-11-08 | 1996-08-14 | 江苏苏晋集团公司 | Natural medicinal health-care products-complex prescription of pearl and snake powder |
| CN1134302A (en) * | 1996-02-09 | 1996-10-30 | 樊丽霞 | Xiaoyinwan pill for treating psoriasis and its producing method |
| CN1165671A (en) * | 1996-05-21 | 1997-11-26 | 李玉英 | Method for prepn. of Chinese medicinal cream for treating psoriasis |
-
1998
- 1998-01-22 CN CN98100151A patent/CN1058631C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1080865A (en) * | 1993-01-05 | 1994-01-19 | 梁建奇 | Dermopathic Chinese medicine of a kind of treatment and preparation method |
| CN1128668A (en) * | 1995-11-08 | 1996-08-14 | 江苏苏晋集团公司 | Natural medicinal health-care products-complex prescription of pearl and snake powder |
| CN1134302A (en) * | 1996-02-09 | 1996-10-30 | 樊丽霞 | Xiaoyinwan pill for treating psoriasis and its producing method |
| CN1165671A (en) * | 1996-05-21 | 1997-11-26 | 李玉英 | Method for prepn. of Chinese medicinal cream for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1223870A (en) | 1999-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1056531C (en) | Chinese medicinal herb composition for treating skin disease | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN1189201C (en) | Externally applied Chinese medicine for treating osteoarthropathy and its prepn process | |
| CN1058631C (en) | Psoriasis capsule | |
| CN1054773C (en) | Chinese patent drug "Bizhengning" for treatment of arthralgia-syndrome | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN109700856A (en) | A kind of Chinese medicine external prescription relieved pain with promoting blood circulation and removing obstruction in channels, relaxing muscles and tendons | |
| CN1225254C (en) | Medicinal composition, its preparation process and use in treating psoriasis | |
| CN1260209A (en) | Medicine for nephritis--Shenyanling | |
| CN1049598C (en) | Chinese medicine prepn for psoriasis and its prepn | |
| CN1557445A (en) | Chinese prepared medicine for treating cervical spondylopathy | |
| CN1059327C (en) | Inflammation diminishing and asthma stopping cream | |
| CN1063650C (en) | Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method | |
| CN101032575A (en) | Chinese traditional medicine for curing angiocardiopathy and cerebrovascular disease | |
| CN1270755C (en) | Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis | |
| CN1207054C (en) | Chinese medicine for treating pelvis, nephritis and kidney injury and preparing method thereof | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1055242C (en) | Chinese medicine for curing aseptic necrosis of head of femur | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1061249C (en) | Quick-acting traditional Chinese medicine for curing hepatitis B | |
| CN1265817C (en) | Bone injury treating Chinese medicine capsule | |
| CN1277559C (en) | Medicine for treating rheumatism and its preparation | |
| CN1150016C (en) | Medicine for treating fever caused by lupus erythematosus and other immunological disease | |
| CN1180808C (en) | Chinese medicine for treating rheumatic and rheumatoid diseases | |
| CN1089605C (en) | Capsule for treatment of leukoderma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |